CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza A/B Typing Kit CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza A Subtyping Kit CDC Human Influenza Virus Real-time RT-PCR Influenza B Lineage Genotyping Kit CDC Hu

Description:

CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Influenza Kits

The Centers for Disease Control and Prevention has designed a comprehensive series of diagnostic kits to accurately and efficiently detect human influenza viruses. These diagnostic panels utilize advanced RT-PCR methodology, a real-time reverse transcription-polymerase chain reaction, to provide highly precise results.

The overall product line includes:
1. Influenza A/B Typing Kit: This kit helps to discern between Influenza A and B, informing appropriate treatment approaches.
2. Influenza A Subtyping Kit: For further classification, this kit is employed to differentiate between various subtypes of Influenza A.
3. Influenza B Lineage Genotyping Kit: This kit is designed to genotype Influenza B strains to facilitate deeper clinical understanding and targeted treatments.
4. Influenza A/H5 Subtyping Kit: This kit can proficiently identify the subtype H5 of Influenza A viruses, often associated with bird flu cases.

Each of these kits offers significant benefits in the timely identification of influenza type, strain, and lineage, allowing for improved patient management. By providing precise and thorough information, these kits assist in reducing the spread of the virus, inform surveillance studies for public health initiatives, and guide the development of annual influenza vaccines.